143 related articles for article (PubMed ID: 33773328)
1. Assessment of Utility in Migraine: Mapping the Migraine-Specific Questionnaire to the EQ-5D-5L.
Ahadi MS; Vahidpour N; Togha M; Daroudi R; Nadjafi-Semnani F; Mohammadshirazi Z; Akbari-Sari A; Ghorbani Z
Value Health Reg Issues; 2021 Sep; 25():57-63. PubMed ID: 33773328
[TBL] [Abstract][Full Text] [Related]
2. Mapping from disease-specific measures to health-state utility values in individuals with migraine.
Gillard PJ; Devine B; Varon SF; Liu L; Sullivan SD
Value Health; 2012 May; 15(3):485-94. PubMed ID: 22583459
[TBL] [Abstract][Full Text] [Related]
3. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
[TBL] [Abstract][Full Text] [Related]
4. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
Moore A; Young CA; Hughes DA
Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280
[TBL] [Abstract][Full Text] [Related]
5. Mapping QLQ-C30 Onto EQ-5D-5L and SF-6D-V2 in Patients With Colorectal and Breast Cancer From a Developing Country.
Yousefi M; Nahvijou A; Sari AA; Ameri H
Value Health Reg Issues; 2021 May; 24():57-66. PubMed ID: 33508752
[TBL] [Abstract][Full Text] [Related]
6. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.
Chen G; Garcia-Gordillo MA; Collado-Mateo D; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellán-Perpiñán JM; Sánchez-Martínez FI
Patient; 2018 Dec; 11(6):665-675. PubMed ID: 29876865
[TBL] [Abstract][Full Text] [Related]
7. Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data.
Neilson AR; Jones GT; Macfarlane GJ; Pathan EM; McNamee P
Eur J Health Econ; 2022 Nov; 23(8):1357-1369. PubMed ID: 35113270
[TBL] [Abstract][Full Text] [Related]
8. Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores.
Meunier A; Soare A; Chevrou-Severac H; Myren KJ; Murata T; Longworth L
Appl Health Econ Health Policy; 2022 Jan; 20(1):119-131. PubMed ID: 34554442
[TBL] [Abstract][Full Text] [Related]
9. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine.
Bagley CL; Rendas-Baum R; Maglinte GA; Yang M; Varon SF; Lee J; Kosinski M
Headache; 2012 Mar; 52(3):409-21. PubMed ID: 21929662
[TBL] [Abstract][Full Text] [Related]
10. Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients.
Ameri H; Yousefi M; Yaseri M; Nahvijou A; Arab M; Akbari Sari A
Expert Rev Pharmacoecon Outcomes Res; 2019 Feb; 19(1):89-96. PubMed ID: 30173585
[TBL] [Abstract][Full Text] [Related]
11. A mapping study in mainland China: predicting EQ-5D-5L utility scores from the psoriasis disability index.
Su J; Liu T; Li S; Zhao Y; Kuang Y
J Med Econ; 2020 Jul; 23(7):737-743. PubMed ID: 32223358
[No Abstract] [Full Text] [Related]
12. HIT-6 and EQ-5D-5L in patients with migraine: assessment of common latent constructs and development of a mapping algorithm.
Oliveira Gonçalves AS; Panteli D; Neeb L; Kurth T; Aigner A
Eur J Health Econ; 2022 Feb; 23(1):47-57. PubMed ID: 34245392
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal assessment of utilities in patients with migraine: an analysis of erenumab randomized controlled trials.
Di Tanna GL; Porter JK; Lipton RB; Hatswell AJ; Sapra S; Villa G
Health Qual Life Outcomes; 2019 Nov; 17(1):171. PubMed ID: 31718662
[TBL] [Abstract][Full Text] [Related]
14. Modeling Monthly Migraine-Day Distributions Using Longitudinal Regression Models and Linking Quality of Life to Inform Cost-Effectiveness Analysis: A Case Study of Fremanezumab in Japanese-Korean Migraine Patients.
Wang X; Yamato K; Kojima Y; Paris JJ; Peterse EFP; Simons MJHG; Bennison C
Pharmacoeconomics; 2023 Oct; 41(10):1263-1274. PubMed ID: 37318748
[TBL] [Abstract][Full Text] [Related]
15. Mapping study of papillary thyroid carcinoma in China: Predicting EQ-5D-5L utility values from FACT-H&N.
Huang D; Peng J; Chen N; Yang Q; Jiang L
Front Public Health; 2023; 11():1076879. PubMed ID: 36908441
[TBL] [Abstract][Full Text] [Related]
16. Health-Related Quality of Life in Migraine: EQ-5D-5L-Based Study in Routine Clinical Practice.
Domitrz I; Golicki D
J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498500
[TBL] [Abstract][Full Text] [Related]
17. Mapping EORTC-QLQ-C30 onto EQ-5D-5L Index in Indonesian Cancer Patients.
Perwitasari DA; Purba FD; Candradewi SF; Marwin M; Permata A; Ulfa Faza MB; Septiantoro BP; Kaptein AA
Asian Pac J Cancer Prev; 2023 Apr; 24(4):1125-1130. PubMed ID: 37116132
[TBL] [Abstract][Full Text] [Related]
18. The psychometric properties of the persian migraine-specific quality of life questionnaire version 2.1 in episodic and chronic migraines.
Zandifar A; Masjedi SS; Haghdoost F; Asgari F; Manouchehri N; Banihashemi M; Najafi MR; Ghorbani A; Zolfaghari B; Gholamrezaei A; Shaygannejad V; Saadatnia M
ScientificWorldJournal; 2013; 2013():950245. PubMed ID: 24068887
[TBL] [Abstract][Full Text] [Related]
19. Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D.
Lamu AN; Olsen JA
Qual Life Res; 2018 Nov; 27(11):2823-2839. PubMed ID: 30173314
[TBL] [Abstract][Full Text] [Related]
20. Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China.
Yang Q; Yu XX; Zhang W; Li H
Health Qual Life Outcomes; 2019 Oct; 17(1):153. PubMed ID: 31615531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
